HomeCompareBMY vs AXP

BMY vs AXP: Dividend Comparison 2026

BMY yields 4.17% · AXP yields 1.10%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AXP wins by $340.9K in total portfolio value· pulled ahead in Year 7
10 years
BMY
BMY
● Live price
4.17%
Share price
$59.73
Annual div
$2.49
5Y div CAGR
37%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$120.5K
Annual income
$39,823.66
Full BMY calculator →
AXP
AXP
● Live price
1.10%
Share price
$297.58
Annual div
$3.28
5Y div CAGR
78.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$461.4K
Annual income
$298,922.75
Full AXP calculator →

Portfolio growth — BMY vs AXP

📍 AXP pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMYAXP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMY + AXP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMY pays
AXP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMY
Annual income on $10K today (after 15% tax)
$354.34/yr
After 10yr DRIP, annual income (after tax)
$33,850.11/yr
AXP
Annual income on $10K today (after 15% tax)
$93.69/yr
After 10yr DRIP, annual income (after tax)
$254,084.34/yr
At 15% tax rate, AXP beats the other by $220,234.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMY + AXP for your $10,000?

BMY: 50%AXP: 50%
100% AXP50/50100% BMY
Portfolio after 10yr
$290.9K
Annual income
$169,373.20/yr
Blended yield
58.22%
📊

Analyst Conviction Gap

Where Wall Street is split right now

BMY
Analyst Ratings
19
Buy
20
Hold
2
Sell
Consensus: Hold
Price Target
$62.73
+5.0% upside vs current
Range: $40.00 — $75.00
Altman Z
2.3
Piotroski
8/9
AXP
Analyst Ratings
21
Buy
32
Hold
4
Sell
Consensus: Hold
Price Target
$374.58
+25.9% upside vs current
Range: $295.00 — $425.00
Altman Z
0.5
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMY buys
0
AXP buys
0
No recent congressional trades found for BMY or AXP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMYAXP
Forward yield4.17%1.10%
Annual dividend / share$2.49$3.28
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR37%78.5%
Portfolio after 10y$120.5K$461.4K
Annual income after 10y$39,823.66$298,922.75
Total dividends collected$91.0K$425.9K
Payment frequencyquarterlyquarterly
SectorHealthcareFinancials
Analyst consensusHoldHold
Analyst price target$62.73$374.58

Year-by-year: BMY vs AXP ($10,000, DRIP)

YearBMY PortfolioBMY Income/yrAXP PortfolioAXP Income/yrGap
1$11,271$571.12$10,897$196.75+$374.00BMY
2$12,884$824.20$12,017$357.65+$867.00BMY
3$14,993$1,206.32$13,516$657.99+$1.5KBMY
4$17,839$1,797.27$15,697$1,234.61+$2.1KBMY
5$21,826$2,738.11$19,188$2,391.92+$2.6KBMY
6$27,643$4,289.31$25,409$4,877.60+$2.2KBMY
7← crossover$36,534$6,955.64$37,962$10,774.96$1.4KAXP
8$50,861$11,770.13$67,475$26,855.93$16.6KAXP
9$75,402$20,980.23$151,831$79,632.36$76.4KAXP
10$120,504$39,823.66$461,382$298,922.75$340.9KAXP

BMY vs AXP: Complete Analysis 2026

BMYHealthcare

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; Opdivo for anti-cancer indications; Pomalyst/Imnovid indicated for patients with multiple myeloma; and Orencia for adult patients with active RA and psoriatic arthritis. It also provides Sprycel for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy for the treatment of patients with unresectable or metastatic melanoma; Abraxane, a protein-bound chemotherapy product; Reblozyl for the treatment of anemia in adult patients with beta thalassemia; and Empliciti for the treatment of multiple myeloma. In addition, the company offers Zeposia to treat relapsing forms of multiple sclerosis; Breyanzi, a CD19-directed genetically modified autologous T cell immunotherapy for the treatment of adult patients with relapsed or refractory large B-cell lymphoma; Inrebic, an oral kinase inhibitor indicated for the treatment of adult patients with myelofibrosis; and Onureg for the treatment of adult patients with AML. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. The company was founded in 1887 and is headquartered in New York, New York.

Full BMY Calculator →

AXPFinancials

American Express Company, together with its subsidiaries, provides charge and credit payment card products, and travel-related services worldwide. The company operates through three segments: Global Consumer Services Group, Global Commercial Services, and Global Merchant and Network Services. Its products and services include payment and financing products; network services; accounts payable expense management products and services; and travel and lifestyle services. The company's products and services also comprise merchant acquisition and processing, servicing and settlement, point-of-sale marketing, and information products and services for merchants; and fraud prevention services, as well as the design and operation of customer loyalty programs. It sells its products and services to consumers, small businesses, mid-sized companies, and large corporations through mobile and online applications, third-party vendors and business partners, direct mail, telephone, in-house sales teams, and direct response advertising. American Express Company was founded in 1850 and is headquartered in New York, New York.

Full AXP Calculator →
📬

Get this BMY vs AXP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMY vs SCHDBMY vs JEPIBMY vs OBMY vs KOBMY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.